Table 1 Association between HSPA2 mRNA expression and clinicopathological features of pancreatic cancer
From: Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma
Variables | No. of cases (n = 104) | HSPA2 mRNA expression | P -value | |
|---|---|---|---|---|
Low (n, %) | High (n, %) | |||
Age (years) | 0.484 | |||
<60 | 43 | 21 (48.8) | 22 (51.2) | |
≥60 | 61 | 28 (44.3) | 33 (54.1) | |
Gender | 0.396 | |||
Male | 82 | 37 (45.1) | 45 (54.9) | |
Female | 22 | 12 (54.5) | 10 (45.5) | |
Tumor size (cm) | 0.024 | |||
<2 | 47 | 32 (68.1) | 15 (31.9) | |
≥2 | 57 | 17 (29.8) | 40 (70.2) | |
Histological grades | 0.012 | |||
Well/Moderate | 56 | 32 (57.0) | 24 (43.0) | |
Poor | 48 | 17 (35.4) | 31 (64.6) | |
TNM stagea | 0.006 | |||
IA-IB | 66 | 35 (53.0) | 31 (47.0) | |
IIA-IIB | 38 | 14 (36.8) | 24 (63.2) | |
Lymph node metastasis | 0.043 | |||
No | 75 | 39 (48.0) | 36 (52.0) | |
Yes | 29 | 10 (44.8) | 19 (55.2) | |
Vascular invasion | 0.062 | |||
No | 80 | 39 (48.8) | 41 (51.2) | |
Yes | 24 | 10 (41.7) | 14 (58.3) | |
CA19-9 (U/ml) | 0.046 | |||
<27 | 27 | 14 (51.9) | 13 (48.1) | |
≥27 | 77 | 35 (45.5) | 42 (54.5) | |
Bilirubin (μmol/l) | 0.178 | |||
<17.1 | 35 | 16 (45.7) | 19 (54.3) | |
≥17.1 | 69 | 33 (47.8) | 36 (52.3) | |